No announcement yet.

Investor Stem Cell Declares 2011 Stem Cell Leaders

  • Filter
  • Time
  • Show
Clear All
new posts

  • Investor Stem Cell Declares 2011 Stem Cell Leaders

    Investor Stem Cell Declares 2011 Stem Cell Leaders

    This year's principal leaders in the sector are as follows: Geron Corporation (NASDAQ;GERN), Advanced Cell Technology (OTC:ACTC), International Stem Cell Corp. (OTC:ISCO), Pluristem Therapeutics Ltd. (Nasdaq:PSTI), Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA), Mesoblast limited (ASX:MSB) Pfizer Inc. (Public, NYSE:PFE) and Novartis AG (ADR) (Public, NYSE:NVS).

    Online PR News – 17-May-2011 –The emerging regenerative medicine sector is heating up. Investor Stem Cell ( is the world’s only online discussion forum dedicated to regenerative medicine bringing investors and stakeholders together.

    Advanced Cell Technology (OTC:ACTC) Currently has two FDA approved trials using (RPE) cells derived from human embryonic stem cells to treat age related macular degeneration and juvenile MD. Issued patent for non-destructive method of harnessing stem cells without destroying the human embryo.

    Geron Corporation (NASDAQ;GERN) Geron is the regenerative sector research Goliath. They are the first company approved by the FDA to use (hESC) to derive its drug GRNOP-1 to treat spinal cord injury. Pipeline of stem cell research consist of cancer, cardio and vascular disease.